Genetic characterization of adult infratentorial gliomas

Journal of Neuro-Oncology

Volumn 91, Issue 3, 2009, Pages 251-255

  Miwa, Tomoru ^a   Hirose, Yuichi ^b   Sasaki, Hikaru ^a   Ikeda, Eiji ^a   Yoshida, Kazunari ^a   Kawase, Takeshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adult infratentorial glioma; Comparative genomic hybridization; EGFR; Gain of 7p; Losses of 1p and 19q; P53

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P35;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CARCINOGENESIS; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 7P; CHROMOSOME 7Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC TRAIT; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR GENETICS; OLIGODENDROGLIOMA; POSTERIOR CRANIAL FOSSA GLIOMA; PROTEIN EXPRESSION;

ADULT; AGED; BRAIN NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; CHROMOSOMES, HUMAN, PAIR 7; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; FRONTAL LOBE; GLIOMA; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 58149467510     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9714-2     Document Type: Article

References (12)

1. Cairncross JG, Ueki K, Zlatescu MC et al (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90(19):1473-1479. doi: 10.1093/jnci/90.19.1473
2. Sasaki H, Zlatescu MC, Betensky RA et al (2001) PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. Am J Pathol 159(1):359-367
3. Hirose Y, Aldape KD, Chang S et al (2003) Grade II astrocytomas are subgrouped by chromosome aberrations. Cancer Genet Cytogenet 142(1):1-7. doi: 10.1016/S0165-4608(02)00791-4
4. Hirose Y, Aldape K, Bollen A et al (2001) Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. Am J Pathol 158(3):1137-1143
5. Zlatescu MC, TehraniYazdi A, Sasaki H et al (2001) Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res 61(18):6713-6715
6. Mueller W, Hartmann C, Hoffmann A et al (2002) Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. Am J Pathol 161(1):313-319
7. Kleihues P, Cavenee WK (eds) (2000) World Health Organization classification of tumors of the nervous system. IARC/WHO, Lyon
8. Hirose Y, Aldape K, Takahashi M et al (2001) Tissue microdissection and degenerate oligonucleotide primed polymerase chain reaction (DOP-PCR) is an effective method to analyze genetic aberrations in invasive tumors. J Mol Diagn 3(2):62-67
9. Henson JW, Hobbs W, Chakravarti A et al (2005) Alterations in p53, p21, and MIB-1 labeling index in primary human astrocytomas following radiation therapy. J Neurooncol 74(2):151-154. doi: 10.1007/ s11060-004-6911-5
10. Reifenberger J, Ring GU, Gies U et al (1996) Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. J Neuropathol Exp Neurol 55(7):822-831. doi: 10.1097/00005072-199607000-00007
11. Hirose Y, Yoshida K (2006) Chromosomal abnormalities subdivide neuroepithelial tumors into clinically relevant groups. Keio J Med 55(2):52-58. doi: 10.2302/kjm.55.52
12. Djalilian HR, Hall WA (1998) Malignant gliomas of the cerebellum: An analytical review. J Neurooncol 36:247-257. doi: 10.1023/A:1005704006244